Pemphigus: An Autoimmune Complex in Dogs and Cats by Takayama, A. K. & Busch, D. S.
Volume 53 | Issue 1 Article 4
1991
Pemphigus: An Autoimmune Complex in Dogs
and Cats
A. K. Takayama
Iowa State University
D. S. Busch
Follow this and additional works at: https://lib.dr.iastate.edu/iowastate_veterinarian
Part of the Immune System Diseases Commons, and the Small or Companion Animal Medicine
Commons
This Article is brought to you for free and open access by the Journals at Iowa State University Digital Repository. It has been accepted for inclusion in
Iowa State University Veterinarian by an authorized editor of Iowa State University Digital Repository. For more information, please contact
digirep@iastate.edu.
Recommended Citation
Takayama, A. K. and Busch, D. S. (1991) "Pemphigus: An Autoimmune Complex in Dogs and Cats," Iowa State University Veterinarian:
Vol. 53 : Iss. 1 , Article 4.
Available at: https://lib.dr.iastate.edu/iowastate_veterinarian/vol53/iss1/4
Pemphigus: An Autoimmune Complex in Dogs and Cats
A. K. Takayama, BBA, BS, DVM*
D.S. Busch, DVM**
Introduction
The nan1e Pemphigus, derived 'from the Greek
word for blister, describes a group of vesiculobull-
ous diseases of the skin of dogs, cats, and hu-
n1ans. The pemphigus complex is an autoim-
mune disease of the skin characterized by lesions
ranging from vesiculobullous/pustular to erosive/
ulcerative. Lesions of pemphigus are due to the
binding of autoantibody to an antigen in the epi-
dermal cell membrane or the glycocalyx causing
a release of an enzyme(s) resulting in disruption
of intercellular attachn1ents and acantholysis. 1
Pemphigus produces lesions that are restricted
to the epidermis. More speci"fically, these lesions
are suprabasilar, each variant being character-
ized by location within the epidermal layer and by
location of lesions on the body.
Pathogenesis
There are several mechanisms proposed for
the breakdown or loss of control in self-tolerance.
Gorman and Werner have proposed the following
mechanisms of autoimmune disease: "(1) poly-
clonal B cell activation -- B cell clones are stimu-
lated by a pathogen as well as autoreactive B cell
clones resulting in the production of autoantibod-
ies, (2) T suppressor cell bypass -- effective T cell
suppression is bypassed when the presence of an
exogenous agent on a cell surface induces a
response to the exogenous antigen and the cell
surface antigen, (3) T suppressor cell dysfunc-
tion-- allows expansion of autoreactive B cell and
T cell clones, (4) increased T helper cell function-
- increases recognition and induction of a re-
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sponse to the host cell antigen by T helper cells,
(5) autoantigen modification -- modification of a
host cell antigen that renders it autoantigenic, (6)
cross-reacting antigens -- sharing of determi-
nants between exogenous antigens and host cell
antigens."5 In addition to these, Muller et al
proposes an inappropriate interleukin 2 produc-
tion and an idiotype-anti-idiotype imbalance as
well as sexual dimorphism ("with female sex
hormones tending to accelerate immune re-
sponses and male sex hormones tending to sup-
press responses") as mechanisms of autoim-
mune diseases.2 The pemphigus complex is a
group of disorders characterized by an inappro-
priate immune response.
Although the exact mechanism of lesions
produced in pemphigus is not fully understood,
Muller et al have proposed a pathomechanism for
lesion production which includes: "(1) the binding
of pemphigus antibody at the glycocalyx of ker-
atinocytes, (2) internalization of the pemphigus
antibody and fusion of the antibody with intracel-
lular Iysosomes, and (3) resultant activation and
release of a keratinocyte proteolytic enzyme
("pempbigus acantholytic factor"), which diffuses
into extracellular space and hydrolyzes the glyco-
calyx" resulting in "acantholysis and blister forma-
tion within the epidermis."2 The acantholysis in
pemphigus has been likened to a Type II hy-
persensitivity reaction. There seems to be a
controversy remaining over whether or not com-
plen1ent is involved in lesion production in pem-
phigus. Muller et al2 believe that "pemphigus
antibody-induced acantholysis is not dependent
on complement or inflammatory cells." However,
Jordan et al state that "complement activation by
pemphigus antibodies provides an additional
mechanism for loss of epidermal cell cohesion in
addition to the plasminogen-plasmin system."3 It
has long been known that complement (espe-
cially C3) deposits are present in pemphigus
lesions as has been shown through immunofluo-
rescence staining, but their role in lesion produc-
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lesion production is still not clear. Medleau et al
seemed to clear up the discrepancy best. She
states that "complement does not appear to have
a primary role (in lesion production) because IgG
from C3-depleted serum can induce acantholysis
in epidermal cell cultures, hO\NeVer, complement
may have a secondary role in that extracellular
proteases released subsequent to pemphigus
binding may generate chemotactic fragments of
C3 or C5 which in turn could recruit polymor-
phonuclear granulocytes into the area."4
Pemphigus Vulgaris
Of the pernphigus complex, pemphigus vul-
garis was first reported in 1975 and has been
recognized in dogs and cats. The disease does
not seem to have any age, breed, or sex predilec-
tions. It is a vesiculobullous disease that quickly
develops into erosive/ulcerative lesions of the
skin, oral cavity, and mucocutaneous junctions.
Muller et al2 report that "ninety percent of dogs and
cats with pemphigus vulgaris have oral lesions."
Pemphigus vulgaris lesions, strictly limited to the
skin, are rare.? In dogs, the cutaneous lesions are
commonly found in the axillary and groin areas.
Although this is a vesiculobullous disorder, ves-
icles are very transient and fragile, thus the clinical
lesions appear as erosions and ulcers bordered
by epidermal collarettes.2,6 The Nikolsky sign is
characteristic of pemphigus and can be elicited by
applying finger pressure at the lateral aspect of an
erosion or to normal-appearing skin, which would
dislodge the epidermis from the dern1is thus cre-
ating a new erosion. This sign mayor may not be
present and is not diagnostic fOr"pemphigus. The
disease may also have systemic effects in which
anorexia, depression, and fever may be present.
In the dog, the list of differential diagnoses for
pemphigus vulgaris include: bullous pemphigoid,
systemic lupus erythematosus, erythema rnulti-
forme, toxic epidermal necrolysis, drug eruption,
mycosis fungoides, Iymphoreticular neoplasia,
candidiasis, and numerous causes of ulcerative
stomatitis.2
In the cat, lesions of pemphigus vulgaris
.con1monly affect the gums, !"ips, hard palate, and
nasal philtrum.6 Vesicles and bullae are rarely
seen, thus erosions and ulcers are the usual
clinical presentations. The list of differential diag-
noses for ulcerative stomatitis in the cat is quite
extensive. According to Manning et al8 the differ-
entials include: recurrent necrotizing stomatitis,
Vincent's stomatitis, renal disease, vitamin defi-
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ciency, diabetes, heavy metal poisonings, viral
diseases (FeLV, feline rhinotracheitis, feline cal-
icivirus), neoplasia, granuloma, pemphigus, and
lupus erythematosus.
Pemphigus Vegetans
Pernphigus vegetans is believed to be a be-
nign variant of pemphigus vulgaris and has been
rarely reported in the dog.2,9 In humans, pem-
phigus vegetans is classified as either the Neu-
mann or the Hallopeau type. Clinically, the Neu-
mann type forms vesicles and bullae as in pem-
phigus vulgaris, but during the healing process
the affected areas form verrucous vegetations.
The Hallopeau type form pustules initially and
also have a papillomatous, proliferative healing
response. 9 There are apparently no age, breed,
or sex predilections. Differentials for pernphigus
vegetans include: bacterial and fungal granulo-
mas, Iymphoreticular neoplasia, mastocytoma,
papilloma and fibropapilloma.2
Pemphigus Foliaceus
Pemphigus foliaceus is considered the most
cornmon form of pemphigus in the dog and cat.
There seems to be no sex predilection. The
disease seems to affect rrliddle-aged dogs and
according to a study done by Ihrke et ai, four
breeds of dogs were at a higher risk: Bearded
Collie, Akita, Newfoundland, and Schipperke. 10
Muller2adds Chow Chows, Doberman Pinschers,
and Dachshunds to the above list of breeds that
are apparently predisposed to pemphigus foli-
aceus. They often have footpad lesions charac-
terized by erythematous swelling at the pad mar-
gins, cracking, and villous hypertrophy (villous
hyperkeratosis or "hard pad").2,1o These footpad
lesions often cause pain with resulting lameness.
Vesicles and bullae are transient and the animals
are usually presented with pustules and erosions
bordered by epidermal collarettes. The epidermal
collarettes with accompanying alopecia, scaling,
and crusting usually start on the face, bridge of the
nose, and pinnae then gradually spread to the
ventrum. As with the other variants of pemphigus
(i.e. -- pemphigus vulgaris), pain and pruritus are
variable and anorexia, depression, and fever are
seen in severely affected animals.2
Scaling and crusting are the most common
clinical signs in cases of pemphigus foliaceus
hence the origin of the name, "foliaceus", mean-
ing leafy.10 Noxon and Myers reported a case of
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pemphigus foliaceus in two Shetland Sheepdog
littermates. They stated that although "pem-
phigus foliaceus generally is not regarded as an
autoimmune disease with strong genetic influ-
ence" they did find two littermates from a litter of
five that were diagnosed as having pemphigus
foliaceus. They went on to state that "familial
occu rrence of pemphigus foliaceus has been
reported in humans and that development of
many autoimmune diseases is determined to a
great extent by inheritance."11
In the cat, pemphigus foliaceus is similar to
what was described above for the dog. It is
characterized by facial exfoliative dermatitis around
the nose, periorbital area, and the pinnae.8 As
with the dog, oral lesions are rare. More com-
monly seen are crusts, scales, alopecia, erosions,
and epidermal collarettes. Footpad lesions can
also occur.
Differentials for facial dermatitis in the cat are
quite extensive: bacterial folliculitis-furunculosis,
fungal dermatitis, demodecosis, allergic dermati-
tis (food), solar dermatitis, squamous cell carci-
noma (white areas), seborrhea, pemphigus, sys-
temic lupus erythematosus, notoedric mange,
sarcoptic mange, otodectic mange, and drug erup-
tion. 8 In dogs the differential list is similar: bacte-
rial folliculitis, dermatophytosis, demodecosis,
dermatophilosis, seborrhea, lupus erythemato-
sus, subcorneal pustular dermatosis, sterile eo-
sinophilic pustulosis, linear IgA dermatosis, zinc-
responsive dermatitis, dermatomyositis, and
Iymphoreticular neoplasia.2
Pemphigus Erythematosus
Pemphigus erythematosus, is thought to be a
benign form of pemphigus foliaceus. No age or
sex predilections are apparent, but Muller et al2
states that in dogs, Collies and German Shepards
may be predisposed to the disease. Lesions are
similar to that of pemphigus foliaceus, however,
the lesions are restricted to the face and ears.
Depigmentation of the nose is often a complica-
tion, thus allowing photodermatitis to be a pos-
sible sequela.2 Differentials are the same as for
pemphigus foliaceus.
Diagnosis
Definitive diagnosis of pemphigus requires a good
history and physical examination, followed by
direct smears, and histopathologic examination
with immunofluorescence or immunoperoxidase
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testing.2,6 It is recommended that histopathology
together with immunopathologic evaluations be
used as the diagnostic approach to autoimmune
skin diseases.4,12 Routine blood work (hemogram,
serum chenlistries) are usually non-specific in the
cases of pemphigus vulgaris and pemphigus foli-
aceus. Results usually reveal a rnild-to-moderate
nonregenerative anemia, mild hypoalbuminemia,
mild-to-moderate increases in globulins, and with
pemphigus foliaceus, a slight eosinophilia.2
Direct smears should be done on intact ves-
icles or pustules. The snlears can be stained with
a variety of preparations including Wright's stain,
new methylene blue, Quick stain, Sedi stain, and
Papanicolau's stain. 12 Microscopic examination
will reveal large numbers of neutroprlils and/or
eosinophils, few bacteria, and acantholytic ker-
atinocytes. The acantholytic cells are highly
suggestive of pernphigus but do not in themselves
offer a definitive diagnosis of pemphigus.
Skin biopsies must be done on intact vesicles,
which may pose a problem in that these vesicles
are very transient and "fragile. Multiple sites may
need to be biopsied to reveal pathologic changes
indicative of pemphigus. Muller et al2 recom-
mends hospitalizing the animal in order to check
its skin every 2 to 4 hours for blisters. They also
go on to state that these "blisters rapidly fill with
leukocytes and grossly and microscopically ap-
pear as pustules which could confuse both the
clinician and the pathologist.2
Histopathologically, "pemphigus vulgaris is
characterized by suprabasilar acantholysis with
resultant cleft and vesicle formation." Single epi-
dermal cells remain attached along the underlying
basement membrane and resemble "a row of
tombstones."2,7 In the cat, classical histopathol-
ogic changes are seldom seen, thus the diagnosis
of pemphigus vulgaris may need to be based on
only direct smears and direct immunofluores-
cence testing. 8 Pemphigus vegetans is charac-
terized histologically by acantholysis, papilloma-
tosis, and intraepidermal microabscesses con-
taining acantholytic keratinocytes, eosinophils,
and/or neutrophils.2,12 Pemphigus foliaceus and
pemphigus erythematosus appear histologically
similar. They are characterized by intragranular
or subcorneal cleft and vesicle formation and
contain neutrophils or eosinophils along with
acantholytic keratinocytes. Cells from the stratum
granulosum are often found attached to the over-
lying stratum corneum within the vesicle and are
termed granular cell "cling-ons."2 Cats with
pemphigus foliaceus and pemphigus erythema-
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tosus have similar histopathologic changes char-
acterized by subcorneal blisters and acantholy-
sis. 8
Muller et al2 also lists histologic findings that
may aid in the diagnosis of pemphigus in dogs and
cats: "(1) a lichenoid cellular infiltrate (mononu-
clear cells, plasma cells, neutrophils, (2) eosino-
philic exocytosis and microabscess formation
within the epidermis or follicular outer root sheath
(pemphigus foliaceus, erythematosus, vegetans),
(3) involvement of the follicular outer root sheath
in the suprabasilar, intraepidermal, intragranular,
or subcorneal acantholytic process, and (4) acan-
tl1olytic, dyskeratotic granular epidermal cells
("grains") at the surface of erosions (pemphigus
foliaceus and erythematosus).2
Immunofluorescence or immunoperoxidase
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pemphigus after all of the above diagnostic "push-
ups" are performed. Direct immunofluorescence
testing seems to be favored over indirect inl-
munofluorescence due to the high nunlber of
negative results with the indirect method. It is
imperative that lesional (intact blisters or pus-
tules) as well as perilesional skin be biopsied.2,6
The presence of inlmunoglobulin (usually IgG)
and occasionally complement deposition in the
intercellular substance helps support a definitive
diagnosis of pemphigus.
Therapy
Therapy of pemphigus is usually based on the
premise of controlling or managing the clinical
manifestations of the disease. This is due to the
fact that medical treatment must be continued for
long periods of time, and often for the life of the
animal. The goal of therapy is irnrnunosuppres-
sian to negatively control or regulate immunologic
reactivity. The immunosuppressive agents com-
monly used in the clinical management of pem-
phigus include the corticosteroids alone or in
conjunction with cytotoxic or imnlunonl0dulating
agents.
The most widely used glucocorticoid for the
initial treatment of pemphigus is prednisolone or
prednisone. Prednisolone must be given in
immunosuppressive doses which range trom 2.2
to 4.4 mg/kg orally each day for dogs. Cats need
a higher dose which ranges trom 4.4 to 6.6 mg/kg
given orally each day.2,6 The dose can be divided
into two treatments, thus stressing that therapy
rnust be individualized in order to minimize ad-
verse side effects (to be discussed below). The
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above recommended dose for initial treatment of
penlphigus has been recognized to control only
about 50% of the cases in terms of remission of
clinical signs.2,14 In a study done by Scott et ai, a
larger dose of prednisolone was used (6.6 mg/kg/
day) in 31 dogs and proved efficacious in 94% in
terms of inducing a remission of primary skin
lesions, however, glucocorticoid side effects were
greatly increased. 15 Cats seem to respond well to
glucocorticoid treatment alone and upon resolu-
tion of primary lesions, cats, as well as dogs, can
be placed on alternate day/night maintenance
prednisolone therapy to maintain remission. 8
An alternative method of corticosteroid treat-
ment in the dog, corticosteroid pulse therapy,
involves the parenteral administration of meth-
ylprednisolone sodium succinate (11 mg/kg IV
over 1 hour for 3 consecutive days).2.1n This
treatment regime was adapted from human
medical therapy for autoimmune skin diseases.
According to White et a11 6, corticosteroid pulse
therapy proved efficacious in rapidly resolving
skin lesions in all the dogs in their study, and did
not elicit any of the adverse side effects linked to
high dose corticosteroid therapy.
Corticosteroids given at immunosuppressive
levels have the following effects: "(1) decrease in
circulating lymphocytes and monocytes, (2) de-
crease in certain lymphocyte and monocyte func-
tional capabilities, and (3) decrease in immunog-
lobulin and complement levels."17 Major side
effects in the study done by Scott et al 15 included
polydipsia, polyuria, polyphagia, lethargy, depres-
sion, muscle wasting, hepatopathy, and pancreati-
tis in addition to infection (especially in the urinary
tract), thromboembolism, gastrointestinal hemor-
rhage, osteoporosis, and cushingoid signs and
symptoms. Gastrointestinal side effects, such as
indigestion and ulceration, caused by high doses
of corticosteroids can be controlled by including
cimetidine in the treatment protocol. Although
thorough research has not fully documented the
use of cimetidine to control gastrointestinal side
effects, its inclusion in the treatnlent protocols has
been clinically efficacious.
Because of the above-mentioned side effects
with the use of high doses of corticosteroids,
chemotherapy can be used in conjunction with
prednisolone. This combination will not only help
minimize side effects due to the prednisolone by
lowering its dose requirements, but will aid in the
treatment of pemphigus if corticosteroids alone
cannot induce remission of the disease. Ihrke et
al reconlmends instituting combination therapy if
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the animal has not shown substantial improve-
ment within 10 days after corticosteroid therapy
was initiated or if the maintenance dosages (less
than or equal to 1.1 mg/kg on alternate days)
cannot be achieved within 3 to 4 weeks. 1O
Cytotoxic agents and immunomodulating drugs
used include: azathioprine, chlorambucil, cyclo-
phosphamide, cyclosporine, aurothioglucose, and
dapsone.2,10,14,15 Dapsone has not been approved
for use in dogs and cats in the United States and
was not found efficacious in the study done by
Scott et al. 15 Muller cautions the use of azathi-
oprine in cats due to their susceptibility to azathi-
oprine toxicity.2
Although chemotherapy and chrysotherapy
will lower the required dosage of corticosteroids,
these drugs are not without adverse side effects
or toxicities. Of the numerous side effects pos-
sible, depending on the drug chosen, of most
importance is myelosuppression which is a com-
mon featu re of all of the above-mentioned cyto-
toxic or immunomodulating drugs. Thus, monitor-
ing the patient with a hemogram at least once a
month will aid in individualizing a suitable treat-
ment regime. Drug dosages should be adjusted
to maintain a leukocyte count of no lower than
3000 per rnm3 to nlinimize risk of infection. Al-
though chrysotherapy has been used success-
fully in several studies10,14,15 it is usually not the
drug of first choice in the clinical management of
pernphigus. Patients are usually started on corti-
costeroids initially, and possibly combination
therapy with azathioprine or cyclophosphamide
later.2,1o
The prognosis for an animal diagnosed as
having pemphigus must be guarded due to the
possibility of life-long treatment and periodic
monitoring regardless of the treatment regime
instituted. The study of pemphigus cornplex in
dogs and cats has brought many insights into the
diagnosis and treatment of the autoimmune disor-
der in both animals and humans.
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